Alice is a European patent attorney in our Life Sciences and Chemistry team, specialising in cellular and biologic therapeutics spanning a range of modalities. Other key areas of her practice include biomarker diagnostics, cell culturing methods, and antibody processing.
Alice works with a diverse client base that spans early-stage start-ups, clinical-stage biotech firms, and large multinationals. In each case, Alice works closely with her clients, carefully aligning global IP strategy with their commercial goals. Her expertise includes drafting patent applications timed to clinical trial disclosures, coordinating worldwide prosecution, and supporting opposition and appeal proceedings at the EPO. She is also experienced in delivering extensive analysis and tailored advice on matters such as patentability and freedom-to-operate.
Alice's research background focuses on emerging immunotherapies, particularly those that target inflammation. More specifically, she has experience working with small molecule channel inhibitors for treatment of autoimmunity, as well as TCR-engineered T cells for treatment of Acute Myeloid Leukaemia. With a background involving various therapeutic platforms, Alice is well equipped to advise and support clients navigating the intellectual property of this complex and competitive space.
Alice has a BSc in Biochemistry and an MSc Immunology, both from Imperial College London. She has experience working in collaborative research during her time at the Francis Crick Institute, and also has industry experience, which was gained at a drug delivery start-up. Alice started her training in 2021, and joined the Life Sciences and Chemistry team at Kilburn & Strode in 2024.